alexa Ultrasonic Tissue Characterization with Common B-mode Device: GLHW | OMICS International
ISSN: 2157-7420
Journal of Health & Medical Informatics

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Ultrasonic Tissue Characterization with Common B-mode Device: GLHW

Kazuo Maeda*

Department of Obstetrics and Gynecology (Honorary Professor), Tottori University Medical School, Yonago, Japan

*Corresponding Author:
Kazuo Maeda
Department of Obstetrics and Gynecology (Emeritus)
Tottori University Medical School
Yonago, Japan, 3-125, Nadamachi
Yonago, Tottoriken, 6830835, Japan
Tel: 81-859-22-6856
Fax: 81-859-22-6856
E-mail: [email protected]

Received date: October 22, 2013; Accepted date: October 23, 2013; Published date: October 28, 2013

Citation: Maeda K (2014) Ultrasonic Tissue Characterization with Common B-mode Device: GLHW. J Health Med Informat 5:e114. doi:10.4172/2157-7420.1000e114

Copyright: © 2014 Maeda K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Health & Medical Informatics


Medical ultrasound is superb in the real-time B-mode, transvaginal scan, 3-4D ultrasound, for the morphological examination and diagnosis. Only the Doppler ultrasound is unique in the functional study of blood flow and fetal movement. Although the advanced ultrasound detected the nature of tissue structure in the brightness, back scatter, texture and so on, the technique needed advance computer and programs, so that most ultrasound user are out of the benefit of tissue characterization, for example, ovarian malignancy is still diagnosed by the B-mode patterns. Maeda searched for stable technique for the B-mode brightness and found the histogram of B-mode brightness, which was easily found in every B-mode machine. However, the mean gray level value changed when the sensitivity was controlled, the contrast of B-mode image changed, and when the subject depth was changed, in the studies with an ultrasound phantom in around 1990. The author then studied the standardization of histogram, and found the histogram base width was stable to the sensitivity control. Then the histogram base width was standardized by dividing with full length of the brightness, and the gray level histogram width (GLHW) value was completed. As the GLHW was not influenced by the sensitivity control, but changed by image contrast, the contrast level was fixed at 2 among multiple levels. The GLHW was stable among various B-mode devices, but a machine was tested using the ultrasound phantom. Now the GLHW could be applied for the tissue characterization with common B-mode machine without special computer or program [1]. The region of interest (ROI) of subject image was 1x1cm in the trial study, but found the ROI size did not influence on the results. Automatic determination was investigated and confirmed no difference to the manual determination. The automation was introduced into the histogram analysis of Aloka B-mode machine, which was expressed by “% W” sign in Aloka histogram analysis at the same time with mean an SD of simple gray level. The %W value was adapted to the studies on the fetal lung tissue maturity, recognizing its utility.

1) The first trial of GLHW was studies on ovarian benign and malignant masses using connecting 5 ROIs of the mass Kihaile PE and Maeda K [1,2]. Coefficient of variation (CV) was large in benign and small in malignant masses, whereas GLHW was larger in malignant masses than benign. Both groups were clearly differentiated by the CV and GLHW. The levels of teratoma were between benign and malignant masses. A uterine cervical cancer in tumor formation showed larger GLHW than 50 Maeda K [1].

2) The GLHW of benign endometrial hyperplasia was larger than normal endometrium, and the GLHW of endometrial cancer was larger than endometrial hyperplasia and larger than 50 (Ito T). A malignancy may be suspected when the GLHW was larger than 50. Normal adult liver GLHW was measured [1]. Hepatic cell malignancy will be the subject of GLHW study.

3) Placental GLHW was measured in every weeks of pregnancy [2]. Grade3 placenta GLHW was definitely larger than normal placenta. A 2nd trimester IUGR was higher than normal placenta, where fibrin deposit in the intervillus space was diagnosed and the GLHW was returned to normal, fetal estimated weight increased to normal and normal neonate was obtained after the continuous 5,000 Uroprin injection to the mother who had positive antigen, while the fetus died in previous pregnancy (Utsu M) [1].

4) Since the GLHW of-stained amniotic fluid was similar to that of fetal colon content, and significantly larger than the normal and clear amniotic fluid [3]. It is clear that the amniotic fluid was stained by fetal meconium discharged by increased colon motion through the loose anal muscle in fetal hypoxia.

5) Fetal periventricular echo density (PVE) was a white echogenic periventricular tissue of fetal brain in B-mode image, which was confirmed by higher GLHW than normal brain in the transvaginal scan, and preceded neonatal periventricular leukomalacia (PVL) and cerebral palsy (CP) in 19% of persisted PVE in preterm fetus until the preterm births [3].

6) The immature fetal lung followed by neonatal respiratory distress syndrome (RDS) has been diagnosed by the chemical or physical properties of amniotic fluid obtained by the amniocentesis so far, but the amniocentesis accompanied possible risk of fetal demise or other complications. Recently the immature fetal lung preceding neonatal RDS after birth was correctly diagnosed for 96% by the GLHW of fetal lung and liver in preterm pregnancy. The ROIs are placed at fetal lung and liver, and the ratio of GLHW values of fetal lung and liver was obtained, then the product of lung and liver GLHW ratio and the weeks of pregnancy was determined. The immature fetal lung to be neonatal RDS was diagnosed when the value was less than 29 with the sensitivity of 96%. The area under curve (AUC) of ROC was 92 [4]. Since fetal liver GLHW was constant during pregnancy its ratio to fetal lung was a valuable standardization, and also it will delete the interdevice difference of GLHW values. Thus, the ratio to fetal liver GLHW is recommended in fetal GLHW investigation. The GLHW study on immature fetal lung is useful because of the same sensitivity as invasive amniocentesis, but also by the protection of the fetus from the risk of invasive amniocentesis, i.e. the GLHW method can be repeated in the same fetus for the monitoring of fetal lung maturity, and for the evaluation of steroid therapy for the preterm fetus. The amniocentesis can be replaced by ultrasonic tissue characterization with GLHW for the diagnosis of fetal lung maturity. The non-invasive technique is very useful in fetal medicine


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 12099
  • [From(publication date):
    June-2014 - Dec 19, 2018]
  • Breakdown by view type
  • HTML page views : 8301
  • PDF downloads : 3798

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjou[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry


[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version